Cencora Inc
NYSE:COR
Cencora Inc
NYSE:COR
Price:
361.8
USD
0.93%
Market Closed
Market Cap:
$70.4B
Relative Value
The Relative Value of one
COR
stock under the Base Case scenario is
679.75
USD.
Compared to the current market price of 361.8 USD,
Cencora Inc
is
Undervalued by 47%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
COR
Relative Value
Base Case
679.75
USD
Undervaluation 47%
Multiples Across Competitors
COR Competitors Multiples
Cencora Inc Competitors
Cencora Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Cencora Inc
NYSE:COR
|
70.4B USD | 0.2 | 43.4 | 15.2 | 19.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
115.9B USD | 0.3 | 26.7 | 18.7 | 21 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
69.7B USD | 0.2 | 43 | 15.1 | 19.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
52.5B USD | 0.2 | 31.6 | 15.2 | 19.7 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.6B AUD | 2.7 | 34.7 | 25.8 | 25.8 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.6B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9B USD | 0.7 | 22.7 | 11.1 | 15.7 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
60.4B CNY | 1.4 | 16.3 | 12.6 | 12.6 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
64.8B HKD | 0.1 | 8.4 | 1.5 | 1.9 | |
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
6.2B USD | 0.8 | 43.5 | 25.3 | 25.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
